Official name:
SironRx Therapeutics Incorporated
Contact Details
|
SironRx Therapeutics Inc
See map: Google Maps |
Corporate Profile
Web Site:
Registration country:
United States
Industry:
Pharmaceuticals
Company type:
Develops regenerative therapies for the treatment of dermal wound repair
Overview
SironRX is developing novel therapies exclusively licensed from Juventas Therapeutics and Cleveland Clinic that promote wound repair and prevent scarring of dermal wounds. Our lead product, JVS-100 is a clinically tested product that encodes Stromal cell-Derived Factor-1 (SDF-1). SDF-1 is produced by the body in response to tissue injury and activates natural repair processes to prevent cell death and recruit stem cells to the damaged organ.
Investors
| Investor | Profile | Amount | Stage | Date | ||
|---|---|---|---|---|---|---|
| AIG Partners | Series A | Sep 2011 | ||||
| BioEnterprise | ||||||
| Cleveland Clinic Foundation | Feb 2011 | |||||
| Early Stage Partners LP | USD | Series A | Aug 2011 | |||
| Fletcher Spaght Venture Partners LP | Series A | Aug 2011 | ||||
| Glengary Ventures LLC | ||||||
| JumpStart Inc | Feb 2011 | |||||
| North Coast Angel Fund | Series A | Aug 2011 | ||||
| Triathlon Medical Ventures LLC |
Current employees
No current employees available
RECORD ID: 139584
